Literature DB >> 34080542

Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.

J Jaiswal1, K Dunlap2, M Griffin2, A Cox3, S N Singer4, K Hascher5, C LoSchiavo3, S M Walters6, M Mumba7.   

Abstract

BACKGROUND: HIV prevention is needed among people who use drugs (PWUD) due to mixing sex and drugs, selling/trading sex, and/or injecting drugs. Pre-exposure prophylaxis (PrEP) is an extremely effective biomedical HIV prevention strategy, but uptake remains low among communities most in need of HIV prevention, including PWUD. Previous studies have found that providers are less willing to prescribe PrEP to PWUD, yet PWUD express high levels of PrEP acceptance. More research is needed to understand how people who provide substance use treatment services think about PrEP to maximize this biomedical prevention strategy.
METHODS: The study conducted semistructured interviews with 29 staff members in two methadone clinic settings in urban northern New Jersey. Staff members included medical providers, methadone counselors, intake coordinators, front desk staff, lab technicians, security guards, and administrative/leadership personnel.
RESULTS: All staff recognized the need for HIV prevention among their patient populations, but most were either unaware of PrEP or unfamiliar with its purpose and how it works. Medical providers were more likely to have some PrEP knowledge in comparison to counselors and other staff, but the former largely did not have in-depth knowledge. Among those familiar with PrEP, many confused PrEP with HIV medication, as Truvada was the only FDA-approved PrEP at the time of the study. About half of participants expressed clear support for PrEP, while the other half expressed mixed or negative attitudes related to HIV, sexual behavior, and mistrust of the medication. Both the positive and negative perceptions entailed stigmatizing elements. RECOMMENDATIONS: Due to patients' frequent interactions with non-medical staff (e.g., front desk staff, lab technicians, etc.), all staff, not only medical personnel, should be aware of PrEP and comfortable discussing it to foster well-informed, nonjudgmental conversations about HIV prevention with patients. PrEP education should specifically address HIV and sexual-related stigma, as even positive perceptions of PrEP may entail stigmatizing elements.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Clinic staff; HIV; HIV prevention; Methadone; OAT; PrEP

Mesh:

Substances:

Year:  2021        PMID: 34080542      PMCID: PMC8496743          DOI: 10.1016/j.jsat.2021.108371

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  40 in total

Review 1.  How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".

Authors:  Sarah K Calabrese; Kristen Underhill
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

2.  Providers should discuss U=U with all patients living with HIV.

Authors:  Sarah K Calabrese; Kenneth H Mayer
Journal:  Lancet HIV       Date:  2019-02-13       Impact factor: 12.767

3.  Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Authors:  E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock
Journal:  AIDS Behav       Date:  2017-04

4.  Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities.

Authors:  Sarah K Calabrese; Douglas S Krakower; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2017-10-19       Impact factor: 9.308

Review 5.  Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs.

Authors:  Hudson Reddon; Brandon D L Marshall; M-J Milloy
Journal:  Lancet HIV       Date:  2018-12-14       Impact factor: 12.767

Review 6.  PrEP Stigma: Implicit and Explicit Drivers of Disparity.

Authors:  Sarit A Golub
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

7.  Transactional Sex, Substance Use, and Sexual Risk: Comparing Pay Direction for an Internet-Based U.S. Sample of Men Who Have Sex with Men.

Authors:  Keosha T Bond; Irene S Yoon; Steven T Houang; Martin J Downing; Christian Grov; Sabina Hirshfield
Journal:  Sex Res Social Policy       Date:  2019-01-03

8.  Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.

Authors:  Sarah K Calabrese; Manya Magnus; Kenneth H Mayer; Douglas S Krakower; Adam I Eldahan; Lauren A Gaston Hawkins; Nathan B Hansen; Trace S Kershaw; Kristen Underhill; Joseph R Betancourt; John F Dovidio
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

9.  Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment.

Authors:  Roman Shrestha; Michael Copenhaver
Journal:  Front Public Health       Date:  2018-07-13

Review 10.  High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.

Authors:  Don C Des Jarlais; Jonathan P Feelemyer; Shilpa N Modi; Abu Abdul-Quader; Holly Hagan
Journal:  BMC Public Health       Date:  2013-01-19       Impact factor: 3.295

View more
  3 in total

1.  Logistical Facilitators and Barriers to PrEP Implementation in Methadone Clinic Settings: Provider and Staff Perspectives.

Authors:  Jessica Jaiswal; Marybec Griffin; Kevin Hascher; Amanda B Cox; Kandyce Dunlap; Suzan Walters; Caleb LoSchiavo; Wanda M Burton; Mercy Mumba
Journal:  J Addict Med       Date:  2022-02-14       Impact factor: 4.647

2.  PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.

Authors:  Suzan M Walters; David Frank; Brent Van Ham; Jessica Jaiswal; Brandon Muncan; Valerie Earnshaw; John Schneider; Samuel R Friedman; Danielle C Ompad
Journal:  AIDS Behav       Date:  2021-10-09

3.  Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.

Authors:  Suzan M Walters; Joey Platt; Amarachi Anakaraonye; Sarit A Golub; Chinazo O Cunningham; Brianna L Norton; Jae M Sevelius; Oni J Blackstock
Journal:  AIDS Behav       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.